Geneva, Oct. 27 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134554) titled 'Multimodal Machine Learning for Predicting Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer' on Oct. 16.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Affiliated Hospital of Wenzhou Medical University
Condition:
Invasive ductal carcinoma of the breast
Intervention:
Poor-response group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-16
Target Sample Size: Poor-response group:200;Good-response group:300;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=347920
...